referring to inversions and breakpoints that would be missed using comparative genome hybridization and fosmid paired-end sequencing. John West, general manager of Illumina's DNA sequencing ...

The Bristol Genomics Facility has the capacity to run both high output and low output next generation sequencing experiments. The Illumina NextSeq500 system is perfect for the sequencing of whole ...

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech ...

Feb 6 (Reuters) - Gene sequencing machine maker Illumina (ILMN.O), opens new tab forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

“This is the same instrument the scientific community has come to rely on for next-generation sequencing, now with upgraded software, new kits, and the option for a lower volume,” Illumina’s ...

SAN DIEGO, Jan. 13, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology ...

Illumina and Regeneron are taking stakes in ... of Health’s All of Us million-person program and other massive DNA sequencing projects. The companies—supported by more than a dozen major ...

an end-to-end Illumina solution for analysis. Over the last six months, Angle has overcome technical issues to successfully use Illumina assays, coupled with their next generation sequencing (NGS) ...

Investing.com -- TD Cowen downgraded Illumina Inc (NASDAQ:ILMN) to "Hold" following the company's fourth-quarter earnings, citing weaker-than-expected next-generation sequencing (NGS) consumable ...